Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A subtype of inflammatory pseudotumor of the liver characterized by a benign, well-circumscribed tumor with diffuse lymphoplasmacytic infiltration with histological features of IgG4-related disease (numerous IgG4-positive plasma cells, prominent eosinophils, stromal fibrosis, fibroblastic proliferations and, frequently, obliterative phlebitis), and that is likely located around the hepatic hilum. Most often it is discovered as an incidental finding.
Biomarker and diagnostic research for lymphoplasmacytic inflammatory pseudotumor of the liver has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for lymphoplasmacytic inflammatory pseudotumor of the liver.
15 publications have been identified in PubMed for lymphoplasmacytic inflammatory pseudotumor of the liver. Research spans Case Report / Case Series (67%), Review / Meta-Analysis (20%), and Diagnostic / Biomarker (7%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 10 | 67% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:36 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
3 |
20% |
Testing and diagnosis research | 1 | 7% |
Disease patterns and progression | 1 | 7% |
Shibusawa S (2026). [PMID: 42096036](https://pubmed.ncbi.nlm.nih.gov/42096036/). *Clin J Gastroenterol*. [Case Report / Case Series]
Yang W (2026). [PMID: 42152215](https://pubmed.ncbi.nlm.nih.gov/42152215/). *J Coll Physicians Surg Pak*. [Case Report / Case Series]
Wang W (2026). [PMID: 42064069](https://pubmed.ncbi.nlm.nih.gov/42064069/). *Front Immunol*. [Case Report / Case Series]
Nguyen ED (2025). [PMID: 39478419](https://pubmed.ncbi.nlm.nih.gov/39478419/). *Histopathology*. [Epidemiology / Natural History]
Descalzo Alfonso M (2025). [PMID: 40503994](https://pubmed.ncbi.nlm.nih.gov/40503994/). *Rev Esp Enferm Dig*. [Review / Meta-Analysis]
Radhakrishnan N (2025). [PMID: 40239161](https://pubmed.ncbi.nlm.nih.gov/40239161/). *Int J Surg Pathol*. [Case Report / Case Series]
Hanafusa R (2025). [PMID: 40526324](https://pubmed.ncbi.nlm.nih.gov/40526324/). *Clin J Gastroenterol*. [Case Report / Case Series]
Beuers U (2025). [PMID: 40342085](https://pubmed.ncbi.nlm.nih.gov/40342085/). *Semin Liver Dis*. [Review / Meta-Analysis]
Sugimoto A (2025). [PMID: 41016808](https://pubmed.ncbi.nlm.nih.gov/41016808/). *J Clin Exp Hematop*. [Case Report / Case Series]
Manni G (2025). [PMID: 41096685](https://pubmed.ncbi.nlm.nih.gov/41096685/). *Int J Mol Sci*. [Review / Meta-Analysis]